Tags

Type your tag names separated by a space and hit enter

Proton pump inhibitors from clinical pharmacists point of view.
Cas Lek Cesk. 2019 Winter; 158(7-8):282-288.CL

Abstract

Proton pump inhibitors (PPIs) are very effective drugs in treatment and prevention of acid-related disorders. They are widely used in gastroesophageal reflux disease, gastroduodenal ulcers, Zollinger-Ellison syndrome or prevention and treatment of NSAIDs induced gastric lesions. They are also used in many other indications, although not always is their use appropriate. PPIs are generally well tolerated and overall benefits outweigh potential harm in most of the patients. However, their long-term use is not without a risk of adverse effects and drug-drug interactions and contributes to medical expenses and polypharmacy. As PPIs belong to most prescribed drugs, we should carefully consider the length of therapy and appropriateness of their use and regularly reevaluate the need for chronic therapy.

Authors

No affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31995994

Citation

Pilková, Alena. "Proton Pump Inhibitors From Clinical Pharmacists Point of View." Casopis Lekaru Ceskych, vol. 158, no. 7-8, 2019, pp. 282-288.
Pilková A. Proton pump inhibitors from clinical pharmacists point of view. Cas Lek Cesk. 2019;158(7-8):282-288.
Pilková, A. (2019). Proton pump inhibitors from clinical pharmacists point of view. Casopis Lekaru Ceskych, 158(7-8), 282-288.
Pilková A. Proton Pump Inhibitors From Clinical Pharmacists Point of View. Cas Lek Cesk. 2019;158(7-8):282-288. PubMed PMID: 31995994.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Proton pump inhibitors from clinical pharmacists point of view. A1 - Pilková,Alena, PY - 2020/1/31/entrez PY - 2020/1/31/pubmed PY - 2020/1/31/medline KW - efficacy KW - gastric toxicity KW - proton pump inhibitors KW - safety SP - 282 EP - 288 JF - Casopis lekaru ceskych JO - Cas. Lek. Cesk. VL - 158 IS - 7-8 N2 - Proton pump inhibitors (PPIs) are very effective drugs in treatment and prevention of acid-related disorders. They are widely used in gastroesophageal reflux disease, gastroduodenal ulcers, Zollinger-Ellison syndrome or prevention and treatment of NSAIDs induced gastric lesions. They are also used in many other indications, although not always is their use appropriate. PPIs are generally well tolerated and overall benefits outweigh potential harm in most of the patients. However, their long-term use is not without a risk of adverse effects and drug-drug interactions and contributes to medical expenses and polypharmacy. As PPIs belong to most prescribed drugs, we should carefully consider the length of therapy and appropriateness of their use and regularly reevaluate the need for chronic therapy. SN - 0008-7335 UR - https://www.unboundmedicine.com/medline/citation/31995994/Proton_pump_inhibitors_from_clinical_pharmacists_point_of_view L2 - https://www.prolekare.cz/linkout/121061 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.